Literature DB >> 35896710

Small fragments of hyaluronan are increased in individuals with obesity and contribute to low-grade inflammation through TLR-mediated activation of innate immune cells.

Mònica Romo1, Cristina López-Vicario1,2, Noelia Pérez-Romero3, Mireia Casulleras1,2, Ana Isabel Martínez-Puchol4, Belén Sánchez1,2, Roger Flores-Costa1,2, José Alcaraz-Quiles1, Marta Duran-Güell1,2, Ainitze Ibarzábal5, Juan José Espert5, Joan Clària1,2,4,6,7, Esther Titos8,9,10,11.   

Abstract

BACKGROUND AND AIM: Extracellular matrix (ECM) components released during excessive fat mass expansion are considered potential endogenous danger/alarm signals contributing to innate immune system activation. The aim of the current study was to specifically measure plasma levels of low molecular weight (LMW) hyaluronan (HA) and to evaluate its role as pro-inflammatory damage-associated molecular pattern (DAMP) on leukocyte response in the context of human obesity. SUBJECTS AND METHODS: Participants were selected according to their body mass index (BMI, kg/m2) as non-obese (BMI < 29.9, n = 18) and obese (BMI > 29.9, n = 33). Plasma samples were size-dependent fractionated using ion-exchange chromatography to specifically obtain LMW HA fractions that were subsequently quantified by ELISA. Cell incubation experiments with synthetic HA molecules were performed on freshly Ficoll-isolated neutrophils (PMN) and peripheral blood monocytes (PBMC). Leukocyte and adipose tissue gene expression was assessed by real-time PCR and NF-κB activation by western blot. Plasma cytokine levels were measured by fluorescent bead-based (Luminex) immunoassay.
RESULTS: We observed a statistically significant increase in the circulating levels of HA fragments of LMW in individuals with obesity which were consistent with significant up-regulated expression of the LMW HA synthesizing enzyme hyaluronan synthase-1 (HAS-1) in obese adipose tissue. Gene expression assessment of HA receptors revealed up-regulated levels for TLR2 in both obese PMN and PBMC. Synthetic HA molecules of different sizes were tested on leukocytes from healthy donors. LMW HA fragments (15-40 kDa) and not those from intermediate molecular sizes (75-350 kDa) induced a significant up-regulation of the expression of major pro-inflammatory cytokines such as IL-1β, MCP-1 and IL-8 in PBMC. Importantly, LMW HA was able to induce the phosphorylation of IKK α/β complex supporting its pro-inflammatory role through NF-κB activation.
CONCLUSION: Circulating LMW HA molecules are elevated in obesity and may play an important role in triggering low-grade inflammation and the development of metabolic complications.
© 2022. The Author(s).

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35896710      PMCID: PMC9584819          DOI: 10.1038/s41366-022-01187-z

Source DB:  PubMed          Journal:  Int J Obes (Lond)        ISSN: 0307-0565            Impact factor:   5.551


  47 in total

Review 1.  Hyaluronan in immune dysregulation and autoimmune diseases.

Authors:  Nadine Nagy; Hedwich F Kuipers; Payton L Marshall; Esther Wang; Gernot Kaber; Paul L Bollyky
Journal:  Matrix Biol       Date:  2018-04-04       Impact factor: 11.583

2.  Hyaluronic acid, an accurate serum marker for severe hepatic fibrosis in patients with non-alcoholic fatty liver disease.

Authors:  Ayako Suzuki; Paul Angulo; James Lymp; Dave Li; Shinji Satomura; Keith Lindor
Journal:  Liver Int       Date:  2005-08       Impact factor: 5.828

3.  4-Methylumbelliferone improves the thermogenic capacity of brown adipose tissue.

Authors:  Maria Grandoch; Ulrich Flögel; Sam Virtue; Julia K Maier; Tomas Jelenik; Christina Kohlmorgen; Kathrin Feldmann; Yanina Ostendorf; Tamara R Castañeda; Zhou Zhou; Yu Yamaguchi; Emmani B M Nascimento; Vivekananda G Sunkari; Christine Goy; Martina Kinzig; Fritz Sörgel; Paul L Bollyky; Patrick Schrauwen; Hadi Al-Hasani; Michael Roden; Susanne Keipert; Antonio Vidal-Puig; Martin Jastroch; Judith Haendeler; Jens W Fischer
Journal:  Nat Metab       Date:  2019-04-22

4.  Regulation of lung injury and repair by Toll-like receptors and hyaluronan.

Authors:  Dianhua Jiang; Jiurong Liang; Juan Fan; Shuang Yu; Suping Chen; Yi Luo; Glenn D Prestwich; Marcella M Mascarenhas; Hari G Garg; Deborah A Quinn; Robert J Homer; Daniel R Goldstein; Richard Bucala; Patty J Lee; Ruslan Medzhitov; Paul W Noble
Journal:  Nat Med       Date:  2005-10-23       Impact factor: 53.440

5.  Peripheral mononuclear blood cells contribute to the obesity-associated inflammatory state independently of glycemic status: involvement of the novel proinflammatory adipokines chemerin, chitinase-3-like protein 1, lipocalin-2 and osteopontin.

Authors:  Victoria Catalán; Javier Gómez-Ambrosi; Amaia Rodríguez; Beatriz Ramírez; Víctor Valentí; Rafael Moncada; Camilo Silva; Javier Salvador; Gema Frühbeck
Journal:  Genes Nutr       Date:  2015-04-14       Impact factor: 5.523

6.  Hyaluronan as a Promising Biomarker for Myocardial Damage.

Authors:  Goktug Savas; Nihat Kalay; Pinar Altin; Gamze Karadas Dursun; Murat Cetin; Metin Aytekin
Journal:  Tohoku J Exp Med       Date:  2019-06       Impact factor: 1.848

Review 7.  Degradative action of reactive oxygen species on hyaluronan.

Authors:  L Soltés; R Mendichi; G Kogan; J Schiller; M Stankovska; J Arnhold
Journal:  Biomacromolecules       Date:  2006-03       Impact factor: 6.988

Review 8.  Hyaluronan fragments produced during tissue injury: A signal amplifying the inflammatory response.

Authors:  Angela Avenoso; Giuseppe Bruschetta; Angela D'Ascola; Michele Scuruchi; Giuseppe Mandraffino; Rosa Gullace; Antonino Saitta; Salvatore Campo; Giuseppe M Campo
Journal:  Arch Biochem Biophys       Date:  2019-01-19       Impact factor: 4.013

Review 9.  Interactions between CD44 and Hyaluronan in Leukocyte Trafficking.

Authors:  Braedon McDonald; Paul Kubes
Journal:  Front Immunol       Date:  2015-02-17       Impact factor: 7.561

View more
  1 in total

Review 1.  Pathophysiological and Therapeutic Roles of Fascial Hyaluronan in Obesity-Related Myofascial Disease.

Authors:  Chiedozie Kenneth Ugwoke; Erika Cvetko; Nejc Umek
Journal:  Int J Mol Sci       Date:  2022-10-06       Impact factor: 6.208

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.